Top 5 News Stories 5/18-5/25
BREAKING NEWS: SENATE PASSES PDUFA:
MassBio Applauds Senators Kerry & Brown for Work on Passage of User Fee Package Link
1. Coughlin and Anderson: Bridging the state’s skills gap MetroWest Daily News – 5/18/12
A study released last month by the UMass Mass BenchMarks program revealed what many already sensed: the Bay State economy is picking up steam, growing at a rate of 4.5 percent, twice the national rate. Link
2. Three life sciences businesses among BBJ’s top 10 Mass High Tech – 5/18/12
On Friday, the Boston Business Journal Research Department published the BBJ 150, a list of the top 150 public companies in Massachusetts, ranked by 2011 revenue. Link
3. Former Secretaries Rubin, Paulson to speak at BIO Mass High Tech – 5/21/12
Former Secretaries of the Treasury Robert E. Rubin and Henry M. Paulson, Jr. will be in Boston June 19 to speak on a panel at the national Biotechnology Industry Organization annual meeting, called the BIO International Convention. The two will discuss the state of the global economy in a lunchtime keynote panel, moderated by BIO President and CEO Jim Greenwood, the organization said. Link
4. Patient-Centered Outcomes Research Institute Seeks Applications to Fund $120 Million in Comparative Clinical Effectiveness Research in 2012 Market Watch – 5/22/12
Funding Announcements tie to Newly Finalized National Priorities for Research and Research Agenda Link
5. Broad Institute cofounder David Altshuler is appointed to Vertex board of directors Boston.com – 5/24/12
Vertex Pharmaceuticals Inc., a Cambridge biotechnology company, announced Thursday that David Altshuler, M.D., has joined its board as an independent director. Link
Posted on May 25, 2012, in MassBio, News Roundup, Policy Briefs and tagged 2012 BIO International Convention, Bob Coughlin, Broad Institute, Comparative Effectiveness Research, Henry Paulson, Massachusetts Life Sciences, PCORI, PDUFA, Robert Rubin, Senator John Kerry, Senator Scott Brown, Vertex. Bookmark the permalink. Leave a Comment.


Leave a Comment
Comments (0)